Clinical Trial Update: Zinc Supplement in Regorafenib Treated mCRC Patient [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on zinc supplementation in regorafenib-treated metastatic colorectal cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer Metastatic

Drugs mentioned

• Regorafenib (regorafenib)
• ZINC (Zinc chloride)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: COMPLETED